Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Completed · Phase 3

Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether receiving paclitaxel and carboplatin with epirubicin is more effective than paclitaxel and carboplatin alone for ovarian epithelial, fallopian tube, or peritoneal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of paclitaxel and carboplatin with or without epirubicin in treating patients who have stage IIB, stage III, or stage IV invasive ovarian epithelial, fallopian tube, or peritoneal cancer.

Key facts

Study ID

NCT00004934

Run by

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Starts

1999-08-01

Expected to finish

2003-05-01

Last updated by the study team

2013-02-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• St. Mary's/Duluth Clinic Cancer Center — Duluth, Minnesota, United States
• U.Z. Gasthuisberg — Leuven, Belgium
• Tom Baker Cancer Center - Calgary — Calgary, Alberta, Canada
• CancerCare Manitoba — Winnipeg, Manitoba, Canada
• Cancer Care Ontario-Hamilton Regional Cancer Centre — Hamilton, Ontario, Canada
• CHUS-Hopital Fleurimont — Fleurimont, Quebec, Canada
• Centre Hospitalier Universitaire de Quebec — Québec, Quebec, Canada
• Aalborg Hospital — Aalborg, Denmark
• Odense University Hospital — Odense, Denmark
• Shaare Zedek Medical Center — Jerusalem, Israel
• Spedali Civili — Brescia, Italy
• Istituto Nazionale per lo Studio e la Cura dei Tumori — Milano (Milan), Italy
• Ospedale di Circolo e Fondazione Macchi — Varese, Italy
• Medisch Spectrum Twente — Enschede, Netherlands
• Norwegian Radium Hospital — Oslo, Norway
• Hospitais da Universidade de Coimbra (HUC) — Coimbra, Portugal
• Instituto Portugues de Oncologia de Francisco Gentil - Centro de Lisboa — Lisbon, Portugal
• Institut d'Oncologia Corachan — Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.